Myocardial Reperfusion Injury
Conditions
Keywords
Acute myocardial infarction, Primary percutaneous coronary intervention, Postconditioning
Brief summary
The POST-conditioning during coronary angioplasty in Acute Myocardial Infarction (POST-AMI) trial will evaluate the usefulness of postconditioning in limiting infarct size and microvascular damage during the early and late phases after AMI.
Detailed description
POST-AMI is a single-center, prospective, randomized trial, with a planned inclusion of 78 patients with ST-elevation Acute Myocardial Infarction (AMI). Patients will be randomly assigned to postconditioning arm (primary angioplasty (PA) and stenting followed by brief episodes of ischemia-reperfusion performed during the first minutes of reperfusion) or non-postconditioning arm (PA and stenting without additional intervention). All patients will be treated medically according to current international guidelines, including glycoprotein IIb/IIIa inhibitors before PCI. The primary end point is to evaluate whether postconditioning, compared to PA without additional intervention, reduces infarct size estimated by magnetic resonance at 30±10 days after the AMI. Secondary end points are microvascular obstruction observed at magnetic resonance, ST-segment elevation resolution, persistent ST-segment elevation, angiographic myocardial blush grade \<2 and non sustained/sustained ventricular tachycardia in the 48 hours following PA. Further secondary end points are enzymatic infarct size, left ventricular remodeling and left ventricular function at magnetic resonance performed at 6±1 months, and the reduction of major adverse cardiac events at 30 days and 6 months.
Interventions
PROCEDUREPostconditioning
Primary angioplasty and stenting followed by brief episodes of ischemia-reperfusion performed during the first minutes of reperfusion
PROCEDUREPrimary angioplasty and stenting without additional intervention
Primary angioplasty and stenting without additional intervention.
Sponsors
University of Padova
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* clinical evidence of myocardial infarction defined by the presence of ischemic chest pain lasting more than 30 minutes, with a time interval from the onset of symptoms less than 6 hours before hospital admission, associated with typical ST-segment elevation on the 12-lead ECG * angiographic-detected culprit lesion with stenosis diameter \>70% and TIMI flow grade \<=1
Exclusion criteria
* previous acute myocardial infarction * previous myocardial revascularization (angioplasty or coronary bypass) * previous heart valve replacement * previous heart transplant * clinical instability precluding the suitability of the study * cardiogenic shock or persistent hypotension (systolic blood pressure \<100 mmHg) * rescue angioplasty after thrombolytic therapy * evidence of coronary collaterals (Rentrop grade\>0) in the risk area * advanced atrioventricular block * significant bradycardia * absence of sinus rhythm * inability to lay flat (due to severe cardiac heart failure/respiratory insufficiency) * history or clinical evidence of bronchospastic lung disease * pregnancy * known existence of a life-threatening disease with a life expectancy \<6 months * inability to give informed consent * any contraindication to undergo cardiac-MRI, such as implanted metallic objects (cardiac pacemakers and/or implantable cardioverter defibrillator, implanted insulin pumps or any other type of electronic devices, cerebral clips, aneurysm clips) or any other contraindication to cardiac-MRI (such as claustrophobia)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Infarct size estimated by magnetic resonance | 30±10 days after myocardial infartion |
Secondary
| Measure | Time frame |
|---|---|
| ST-segment elevation resolution | First post-intervention ECG |
| Persistent ST-segment elevation | At 24 and 48 hours post-intervention ECG |
| Angiographic myocardial blush grade <2 | After primary angioplasty |
| Microvascular obstruction observed at magnetic resonance | 30±10 days after myocardial infarction |
| Enzymatic infarct size | Within 7 days after myocardial infarction |
| Left ventricular remodeling and left ventricular function at MRI | At 6±1 months |
| Incidence of Major Adverse Cardiac Events (MACE), defined as the combination of death, re-infarction, re-hospitalization for heart failure or repeat revascularization | At 30 days and at 6 months |
| Non sustained/sustained ventricular tachycardia | Within 48 hours after miocardial infarction |
Countries
Italy
Outcome results
None listed